RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition

Metastasis is the end stage of renal cell carcinoma (RCC), and clear cell renal cell carcinoma (ccRCC) is the most common malignant subtype. The hypoxic microenvironment is a common feature in ccRCC and plays an essential role in the regulation of epithelial–mesenchymal transition (EMT). Accumulating evidence manifests that long non‐coding RNAs (lncRNAs) participate in RCC tumorigenesis and regulate hypoxia‐induced EMT. Here, we identified a lncRNA RP11‐367G18.1 induced by hypoxia, that was overexpressed in ccRCC tissues.

[1]  Jingcheng Zhou,et al.  Belzutifan: a novel therapy for von Hippel–Lindau disease , 2022, Nature Reviews Nephrology.

[2]  W. Linehan,et al.  Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. , 2021, The New England journal of medicine.

[3]  Jian-ping Guo,et al.  Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis , 2021, Oncogene.

[4]  Wei-Chung Cheng,et al.  Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma , 2021, Molecular therapy. Nucleic acids.

[5]  Kou-Juey Wu,et al.  The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis , 2021, Biomedical journal.

[6]  Hua Gan,et al.  An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma , 2021, Frontiers in Oncology.

[7]  A. Kourtidis,et al.  LNCcation: lncRNA localization and function , 2021, The Journal of cell biology.

[8]  Kou-Juey Wu,et al.  Induction of epithelial-mesenchymal transition (EMT) by hypoxia-induced lncRNA RP11-367G18.1 through regulating the histone 4 lysine 16 acetylation (H4K16Ac) mark. , 2021, American journal of cancer research.

[9]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[10]  Wei-Chung Cheng,et al.  Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach , 2020, Scientific Reports.

[11]  Yao Lin,et al.  Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma , 2020, Frontiers in Oncology.

[12]  Ying Hu,et al.  Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis. , 2020, Cancer letters.

[13]  P. Seidel,et al.  HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice , 2020, Nature Communications.

[14]  Kou-Juey Wu,et al.  Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulators. , 2020, Cancer letters.

[15]  Wei-Chung Cheng,et al.  DriverDBv3: a multi-omics database for cancer driver gene research , 2019, Nucleic Acids Res..

[16]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[17]  F. Liu,et al.  A Long Noncoding RNA, Antisense IL-7, Promotes Inflammatory Gene Transcription through Facilitating Histone Acetylation and Switch/Sucrose Nonfermentable Chromatin Remodeling , 2019, The Journal of Immunology.

[18]  C. Porta,et al.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  W. Rathmell,et al.  Epigenetic modifiers: activities in renal cell carcinoma , 2018, Nature Reviews Urology.

[20]  Ruidong Li,et al.  GDCRNATools: an R/Bioconductor package for integrative analysis of lncRNA, miRNA, and mRNA data in GDC , 2017, bioRxiv.

[21]  Xing Luo,et al.  Long Non-Coding RNA Emergence During Renal Cell Carcinoma Tumorigenesis , 2018, Cellular Physiology and Biochemistry.

[22]  M. Esteller,et al.  Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer? , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[23]  Shou‐Tung Chen,et al.  The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death , 2018, International journal of molecular sciences.

[24]  Robert A. Weinberg,et al.  EMT in cancer , 2018, Nature Reviews Cancer.

[25]  M. Stöckle,et al.  Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI , 2017, Scientific Reports.

[26]  M. Stöckle,et al.  Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI , 2017, Scientific Reports.

[27]  P. Piña-Sánchez,et al.  Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response , 2017, Clinical Epigenetics.

[28]  Charles Swanton,et al.  Renal cell carcinoma , 2017, Nature Reviews Disease Primers.

[29]  R. Motzer,et al.  Systemic Therapy for Metastatic Renal-Cell Carcinoma. , 2017, The New England journal of medicine.

[30]  H. Moch,et al.  Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. , 2016, European urology.

[31]  A. Harris,et al.  The tumour hypoxia induced non-coding transcriptome. , 2016, Molecular aspects of medicine.

[32]  N. Brockdorff,et al.  The interplay of histone modifications – writers that read , 2015, EMBO reports.

[33]  N. Mongan,et al.  The role of HIF1α in renal cell carcinoma tumorigenesis , 2014, Journal of Molecular Medicine.

[34]  Lin Zhang,et al.  Methods for the study of long noncoding RNA in cancer cell signaling. , 2014, Methods in molecular biology.

[35]  Lars Egevad,et al.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.

[36]  B. Wilson,et al.  Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor–mediated upregulation of caveolin-1 , 2012, Proceedings of the National Academy of Sciences.

[37]  Howard Y. Chang,et al.  Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. , 2011, Molecular cell.

[38]  J. Tostain,et al.  Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. , 2010, European journal of cancer.

[39]  R. Uzzo,et al.  Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  N. Jonjić,et al.  Hypoxia inducible factor-1α correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[41]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[42]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[43]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .